Cell-based ELISA using intact HEp-2 cells: an alternative approach for antinuclear antibody detection

Area of Science:

• Immunology
• Biochemistry
• Clinical Diagnostics

Background:

• Antinuclear antibodies (ANAs) are crucial biomarkers for diagnosing and monitoring autoimmune diseases.
• Traditional ANA detection methods, like indirect immunofluorescence (IFA), lack standardization and quantitative capabilities.
• There is a need for a more precise and reproducible assay for ANA detection.

Purpose of the Study:

• To develop a standardized, quantitative HEp-2 cell-based ELISA for detecting antinuclear antibodies (ANAs).
• To evaluate the feasibility and performance of this ELISA as an alternative to conventional ANA detection techniques.

Main Methods:

• HEp-2 cells were cultured and fixed on ELISA plates.
• Cells underwent fixation, permeabilization, and blocking steps using various reagents.
• Sera were analyzed using indirect ELISA, with three different HRP-conjugated secondary antibodies tested.

Main Results:

• The developed HEp-2 cell-based ELISA effectively distinguished between ANA-positive and ANA-negative samples.
• The anti-IgG gamma chain secondary antibody demonstrated the lowest non-specific binding.
• The assay achieved a sensitivity of 87.5% and a specificity of 81.25%, with low intra- and inter-assay variation.

Conclusions:

• The HEp-2 cell-based ELISA is a viable and promising method for quantitative ANA detection.
• This assay provides a practical alternative to traditional methods for both research and diagnostic applications.
• The method offers reliable differentiation between positive and negative ANA samples.